Second-line-Therapie des Ovarialkarzinoms

Publisher： Karger

E-ISSN： 2296-5262|23|6|593-596

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.6, 2001-01, pp. : 593-596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Irinotecan – klinischer Fortschritt in der Second-line-Therapie des fortgeschrittenen Kolorektalkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 28-31

Karger

Access to resources Recommend Favorite

Docetaxel in der First- und Second-line-Therapie des Magenkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 40-42

Karger

Access to resources Recommend Favorite

Standards in der Therapie des Ovarialkarzinoms

By Pfisterer J.   du Bois A.  

Der Pathologe, Vol. 28, Iss. 3, 2007-05 ,pp. : 222-228

Springer Publishing Company

Access to resources Recommend Favorite

Caelyx® in der Therapie des fortgeschrittenen Ovarialkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 40-45

Karger

Access to resources Recommend Favorite

Therapie bei Progression und Rezidiv des Ovarialkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 35-39

Karger

Access to resources Recommend Favorite